For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets innovative interventional MRI ("iMRI") procedures, is ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, is ...
Investigators conducted a meta-analysis of 4 randomized controlled trials including a total of more than 1000 men with prostate cancer.
Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But ...
If you’re a man over 50 reading this with a cup of coffee in one hand, there’s a fair chance you’ve already been up to the ...
Benign Prostatic Hyperplasia (BPH), or prostate enlargement, is a common condition affecting aging men in India. It often ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. In a post on X on Friday, Netanyahu wrote he had undergone treatment at ...
Getting your prostate removed can seem daunting, and recovery can involve coping with some temporary but significant changes to your urinary, sexual, and mental health. However, the five-year survival ...
Diagnosed with cancer post prostate enlargement surgery, the UK monarch's health is reportedly not very well. Veteran royal correspondent Robert Jobson revealed what is actually happening to the King ...
King Charles Latest Health Updates: Is Buckingham Palace hiding something majorly serious regarding the monarch's health? After a brief period, King Charles' health is again under scrutiny. The ...
Side effects like incontinence and erectile dysfunction can wreak havoc on your emotions. Here’s how to feel like yourself again. When this cancer is caught in its early stages, before it has spread ...